The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells
Open accessAbstract
Arginase 1 (Arg1) and indoleamine 2,3-dioxygenase 1 (IDO1) are immunoregulatory enzymes catalyzing the degradation of l-arginine and l-tryptophan, respectively, resulting in local amino acid deprivation. In addition, unlike Arg1, IDO1 is also endowed with non-enzymatic signaling activity in dendritic cells (DCs). Despite considerable knowledge of their individual biology, no integrated functions of Arg1 and IDO1 have been reported yet. We found that IDO1 phosphorylation and consequent activation of IDO1 signaling in DCs was strictly dependent on prior expression of Arg1 and Arg1-dependent production of polyamines. Polyamines, either produced by DCs or released by bystander Arg1 + myeloid-derived suppressor cells, conditioned DCs toward an IDO1-dependent, immunosuppressive phenotype via activation of the Src kinase, which has IDO1-phosphorylating activity. Thus our data indicate that Arg1 and IDO1 are linked by an entwined pathway in immunometabolism and that their joint modulation could represent an important target for effective immunotherapy in several disease settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Arginine metabolism: nitric oxide and beyond
WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
Self-citationMetabolic Pathways in Immune Cell Activation and Quiescence
Pearce, E. L., & Pearce, E. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.005 · Cited by 1,692
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Youn, J.-I., Nagaraj, S., Collazo, M., & Gabrilovich, D. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5791 · Cited by 1,645
CTLA-4–Ig regulates tryptophan catabolism in vivo
Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M. L., Bianchi, R., Fioretti, M. C., et al. (2002) · Nature Immunology · doi:10.1038/ni846 · Cited by 1,161
Self-citationPolyamines and cancer: old molecules, new understanding
Gerner, E. W., & Meyskens, F. L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1454 · Cited by 1,159
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Marvel, D., & Gabrilovich, D. I. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80005 · Cited by 1,050
Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C., Bianchi, R., Belladonna, M. L., Volpi, C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6752 · Cited by 1,047
Self-citationOrigin and evolution of the adaptive immune system: genetic events and selective pressures
Flajnik, M. F., & Kasahara, M. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2703 · Cited by 931
The roles of TGFβ in the tumour microenvironment
Pickup, M., Novitskiy, S., & Moses, H. L. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3603 · Cited by 917
Tolerogenic dendritic cells and the quest for transplant tolerance
Morelli, A. E., & Thomson, A. W. (2007) · Nature Reviews Immunology · doi:10.1038/nri2132 · Cited by 899
Transforming growth factor-β in T-cell biology
Gorelik, L., & Flavell, R. A. (2002) · Nature Reviews Immunology · doi:10.1038/nri704 · Cited by 792
Tolerance, DCs and tryptophan: much ado about IDO
Grohmann, U. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00072-3 · Cited by 766
Self-citationMassagué, J., & Gomis, R. R. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.033 · Cited by 721
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells
Pallotta, M. T., Orabona, C., Volpi, C., Vacca, C., Belladonna, M. L., Bianchi, R., Servillo, G., Brunacci, C., Calvitti, M., Bicciato, S., et al. (2011) · Nature Immunology · doi:10.1038/ni.2077 · Cited by 703
Self-citationTryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion
Platten, M., Wick, W., & Van den Eynde, B. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0569 · Cited by 703
Aryl hydrocarbon receptor control of a disease tolerance defence pathway
Bessede, A., Gargaro, M., Pallotta, M. T., Matino, D., Servillo, G., Brunacci, C., Bicciato, S., Mazza, E. M. C., Macchiarulo, A., Vacca, C., et al. (2014) · Nature · doi:10.1038/nature13323 · Cited by 674
Self-citationTumor‐induced tolerance and immune suppression by myeloid derived suppressor cells
Marigo, I., Dolcetti, L., Serafini, P., Zanovello, P., & Bronte, V. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00602.x · Cited by 608
Self-citationOstrand-Rosenberg, S., Sinha, P., Beury, D. W., & Clements, V. K. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.01.011 · Cited by 583
Ugel, S., De Sanctis, F., Mandruzzato, S., & Bronte, V. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80006 · Cited by 559
Self-citationDefective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease
Romani, L., Fallarino, F., De Luca, A., Montagnoli, C., D’Angelo, C., Zelante, T., Vacca, C., Bistoni, F., Fioretti, M. C., Grohmann, U., et al. (2008) · Nature · doi:10.1038/nature06471 · Cited by 535
Self-citationIDO and regulatory T cells: a role for reverse signalling and non-canonical NF-κB activation
Puccetti, P., & Grohmann, U. (2007) · Nature Reviews Immunology · doi:10.1038/nri2163 · Cited by 453
Self-citationLaouar, Y., Sutterwala, F. S., Gorelik, L., & Flavell, R. A. (2005) · Nature Immunology · doi:10.1038/ni1197 · Cited by 451
Self-citationTransforming growth factor beta (TGF-β) and inflammation in cancer
Bierie, B., & Moses, H. L. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.008 · Cited by 334
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy
Grohmann, U., Volpi, C., Fallarino, F., Bozza, S., Bianchi, R., Vacca, C., Orabona, C., Belladonna, M. L., Ayroldi, E., Nocentini, G., et al. (2007) · Nature Medicine · doi:10.1038/nm1563 · Cited by 318
Self-citationZhang, M., Caragine, T., Wang, H., Cohen, P. S., Botchkina, G., Soda, K., Bianchi, M., Ulrich, P., Cerami, A., Sherry, B., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.10.1759 · Cited by 317
Control of immune response by amino acid metabolism
Grohmann, U., & Bronte, V. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00915.x · Cited by 308
Self-citationAmino acid auxotrophy as a system of immunological control nodes
Murray, P. J. (2016) · Nature Immunology · doi:10.1038/ni.3323 · Cited by 249
Enhancer-Mediated Control of Macrophage-Specific Arginase I Expression
Pauleau, A.-L., Rutschman, R., Lang, R., Pernis, A., Watowich, S. S., & Murray, P. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7565 · Cited by 243
The Immune System as a Sensor of the Metabolic State
Odegaard, J. I., & Chawla, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.001 · Cited by 216
Orabona, C., Pallotta, M. T., Volpi, C., Fallarino, F., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Grohmann, U., & Puccetti, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810278105 · Cited by 204
Self-citationDuration, combination and timing: the signal integration model of dendritic cell activation
Macagno, A., Napolitani, G., Lanzavecchia, A., & Sallusto, F. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.03.008 · Cited by 204
Boutard, V, Havouis, R., Fouqueray, B., Philippe, C., Moulinoux, J. P., & Baud, L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.2077 · Cited by 186
Chen, W. (2011) · Nature Immunology · doi:10.1038/ni.2088 · Cited by 182
The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity
Fazekas de St Groth, B. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01328-0 · Cited by 169
Host Immune Response to Infection and Cancer: Unexpected Commonalities
Goldszmid, R. S., Dzutsev, A., & Trinchieri, G. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.003 · Cited by 165
Cutting Edge: Autocrine TGF-β Sustains Default Tolerogenesis by IDO-Competent Dendritic Cells
Belladonna, M. L., Volpi, C., Bianchi, R., Vacca, C., Orabona, C., Pallotta, M. T., Boon, L., Gizzi, S., Fioretti, M. C., Grohmann, U., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5194 · Cited by 164
Self-citationInterleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes.
Musso, T., Gusella, G., Brooks, A., Longo, D., & Varesio, L. (1994) · Blood · doi:10.1182/blood.v83.5.1408.1408 · Cited by 158
Evolution of Vertebrate Indoleamine 2,3-Dioxygenases
Yuasa, H., Takubo, M., Takahashi, A., Hasegawa, T., Noma, H., & Suzuki, T. (2007) · Journal of Molecular Evolution · doi:10.1007/s00239-007-9049-1 · Cited by 134
TGF-β and kynurenines as the key to infectious tolerance
Belladonna, M. L., Orabona, C., Grohmann, U., & Puccetti, P. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.11.006 · Cited by 134
Self-citationFunctional Plasticity of Dendritic Cell Subsets as Mediated by CD40 Versus B7 Activation
Grohmann, U., Bianchi, R., Orabona, C., Fallarino, F., Vacca, C., Micheletti, A., Fioretti, M. C., & Puccetti, P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2581 · Cited by 106
Self-citationGene duplication and the evolution of moonlighting proteins
Espinosa‐Cantú, A., Ascencio, D., Barona‐Gómez, F., & DeLuna, A. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00227 · Cited by 89
Orabona, C., Pallotta, M. T., & Grohmann, U. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00029 · Cited by 86
Self-citationvan Baal, J. W. P. M., Diks, S. H., Wanders, R. J. A., Rygiel, A. M., Milano, F., Joore, J., Bergman, J. J. G. H. M., Peppelenbosch, M. P., & Krishnadath, K. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1370 · Cited by 83
Self-citationYe, C., Geng, Z., Dominguez, D., Chen, S., Fan, J., Qin, L., Long, A., Zhang, Y., Kuzel, T. M., & Zhang, B. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500729 · Cited by 70
Pallotta, M. T., Orabona, C., Bianchi, R., Vacca, C., Fallarino, F., Belladonna, M. L., Volpi, C., Mondanelli, G., Gargaro, M., Allegrucci, M., et al. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12360 · Cited by 64
Self-citationEvolution of an ancient protein function involved in organized multicellularity in animals
Anderson, D. P., Whitney, D. S., Hanson-Smith, V., Woznica, A., Campodonico-Burnett, W., Volkman, B. F., King, N., Thornton, J. W., & Prehoda, K. E. (2016) · eLife · doi:10.7554/elife.10147 · Cited by 64
TGFβ in T cell biology and tumor immunity: Angel or devil?
Tu, E., Chia, P. Z. C., & Chen, W. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.014 · Cited by 61
The Coevolution of IDO1 and AhR in the Emergence of Regulatory T-Cells in Mammals
Grohmann, U., & Puccetti, P. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00058 · Cited by 57
Self-citationYang, Q., Wei, J., Zhong, L., Shi, M., Zhou, P., Zuo, S., Wu, K., Zhu, M., Huang, X., Yu, Y., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00805-14 · Cited by 52
Indoleamine 2,3-Dioxygenase and Regulatory Function: Tryptophan Starvation and Beyond
Orabona, C., & Grohmann, U. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-869-0_19 · Cited by 51
Self-citationTrial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy
Buqué, A., Bloy, N., Aranda, F., Cremer, I., Eggermont, A. M. M., Fridman, W. H., Fucikova, J. P., Galon, J., Špíšek, R., Tartour, É., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1149674 · Cited by 50
Haploinsufficiency for Odc Modifies Mouse Skin Tumor Susceptibility
Guo, Y., Cleveland, J. L., & O’Brien, T. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3244 · Cited by 46
Cervelli, M., Angelucci, E., Germani, F., Amendola, R., & Mariottini, P. (2013) · Amino Acids · doi:10.1007/s00726-013-1572-3 · Cited by 39
Polyamine blockade promotes antitumor immunity
Hayes, C. S., Burns, M. R., & Gilmour, S. K. (2014) · OncoImmunology · doi:10.4161/onci.27360 · Cited by 38
Volpi, C., Mondanelli, G., Pallotta, M. T., Vacca, C., Iacono, A., Gargaro, M., Albini, E., Bianchi, R., Belladonna, M. L., Célanire, S., et al. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.036 · Cited by 32
Self-citationSpermine, a Molecular Switch Regulating EGFR, Integrin β3, Src, and FAK Scaffolding
Ray, R., Li, C.-Y., Bhattacharya, S., Naren, A., & Johnson, L. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.12.016 · Cited by 24
Is Co-option a Prevailing Mechanism during Cancer Progression?
Billaud, M., & Santoro, M. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2158 · Cited by 17
Cited by
Mechanisms of resistance to immune checkpoint inhibitors
Jenkins, R. W., Barbie, D. A., & Flaherty, K. T. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.434 · Cited by 1,383
Amino Assets: How Amino Acids Support Immunity
Kelly, B., & Pearce, E. L. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.010 · Cited by 643
The hallmarks of successful anticancer immunotherapy
Galluzzi, L., Chan, T. A., Kroemer, G., Wolchok, J. D., & López-Soto, A. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat7807 · Cited by 575
Thomas, T., Stefanoni, D., Reisz, J. A., Nemkov, T., Bertolone, L., Francis, R. O., Hudson, K. E., Zimring, J. C., Hansen, K. C., Hod, E. A., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.140327 · Cited by 586
Targeted deletion of PD-1 in myeloid cells induces antitumor immunity
Strauss, L., Mahmoud, M. A. A., Weaver, J. D., Tijaro-Ovalle, N. M., Christofides, A., Wang, Q., Pal, R., Yuan, M., Asara, J., Patsoukis, N., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.aay1863 · Cited by 437
Metadata
- Authors
- Mondanelli, G., Bianchi, R., Pallotta, M. T., Orabona, C., Albini, E., Iacono, A., Belladonna, M. L., Vacca, C., Fallarino, F., Macchiarulo, A., Ugel, S., Bronte, V., Gevi, F., Zolla, L., Verhaar, A., Peppelenbosch, M., Mazza, E. M. C., Bicciato, S., Laouar, Y., Santambrogio, L., Puccetti, P., Volpi, C., & Grohmann, U.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 46
- Issue
- 2
- Pages
- 233-244
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2588356762
- Cited by
- 333
- References
- 62
- FWCI
- 11.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.